Two thirds of COVID-19 patients improve after Gilead drug – NEJM – Yahoo Finance
Business News
- Two thirds of COVID-19 patients improve after Gilead drug – NEJM Yahoo Finance
- Gilead’s experimental drug remdesivir shows ‘hopeful’ signs in small group of coronavirus patients The Washington Post
- Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM nejm.org
- Gilead drug shows positive signs in early coronavirus testing Financial Times
- Potential Coronavirus Drugs May Cost as Little as $1, Study Says Bloomberg
- View Full Coverage on Google News
Source: Business News
